Nilsson T, JONSSON G
Cancer Chemother Rep. 1975 Jan-Feb;59(1):229-32.
The clinical results with estramustine phosphate in far-advanced carcinoma of the prostate refractory to other treatments are presented. Good clinical results have been achieved in about 40 percent of the 90 patients treated and regression of metastases has occurred in about 20 percent. Estramustine phosphate in the primary treatment of far-advanced carcinoma of the prostate shows very good and promising clinical results. A total of 132 patients were treated.
本文介绍了磷酸雌莫司汀治疗其他治疗方法无效的晚期前列腺癌的临床结果。在接受治疗的90例患者中,约40%取得了良好的临床效果,约20%出现了转移灶消退。磷酸雌莫司汀在晚期前列腺癌的初始治疗中显示出非常良好且有前景的临床效果。总共治疗了132例患者。